IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.621
AS - Asia 4.009
EU - Europa 758
SA - Sud America 167
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 31
OC - Oceania 20
Totale 11.716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.796
TR - Turchia 2.043
SG - Singapore 987
CA - Canada 787
CN - Cina 768
IT - Italia 235
BR - Brasile 152
DE - Germania 126
EU - Europa 110
IE - Irlanda 76
GB - Regno Unito 66
UA - Ucraina 53
IN - India 44
HK - Hong Kong 36
RU - Federazione Russa 29
JP - Giappone 26
FI - Finlandia 25
MX - Messico 25
BD - Bangladesh 22
FR - Francia 21
PL - Polonia 20
NL - Olanda 18
SE - Svezia 17
VN - Vietnam 17
ES - Italia 14
KR - Corea 14
AU - Australia 12
GR - Grecia 11
ZA - Sudafrica 11
LT - Lituania 10
DK - Danimarca 9
EG - Egitto 9
RO - Romania 8
IL - Israele 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
AR - Argentina 5
CH - Svizzera 5
JO - Giordania 4
PK - Pakistan 4
SA - Arabia Saudita 4
TH - Thailandia 4
NI - Nicaragua 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
UZ - Uzbekistan 3
BB - Barbados 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
NP - Nepal 2
PH - Filippine 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CO - Colombia 1
DJ - Gibuti 1
GF - Guiana Francese 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
Totale 11.716
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
Toronto 753
Dallas 604
Chandler 392
Houston 382
Wilmington 373
Santa Clara 371
Singapore 323
Lawrence 249
Princeton 249
Ashburn 195
Beijing 155
Fairfield 151
Los Angeles 111
Woodbridge 88
Seattle 79
Shanghai 69
Guangzhou 61
Rome 40
Hong Kong 34
Shenzhen 34
Cambridge 33
Munich 32
Dublin 29
Brooklyn 26
São Paulo 26
Milan 24
New York 21
Boston 20
Wuhan 19
Helsinki 18
Jiaxing 18
Rui'an 18
Council Bluffs 17
Assago 16
Warsaw 16
Boardman 15
Tokyo 15
Mexico City 14
Chennai 13
Montreal 13
Chicago 12
Frankfurt am Main 12
London 12
San Francisco 12
Stockholm 12
The Dalles 12
Xi'an 11
Quanzhou 10
Ho Chi Minh City 9
Redwood City 9
Washington 9
Wuxi 9
Xuzhou 9
Belo Horizonte 8
Johannesburg 8
Phoenix 8
Pune 8
West Jordan 8
Andover 7
Ankara 7
Manchester 7
Nanjing 7
Redmond 7
Solagna 7
St Petersburg 7
Amsterdam 6
Ar Riyāḑ 6
Denver 6
Dhaka 6
Kyiv 6
Nairobi 6
Naples 6
Timisoara 6
Atlanta 5
Dongyang 5
Florence 5
Melbourne 5
Moscow 5
Mumbai 5
Rockville 5
Amman 4
Auckland 4
Austin 4
Bologna 4
Chiang Mai 4
Clifton 4
Columbus 4
Incheon 4
Ljubljana 4
Maceió 4
Minoh 4
Montegabbione 4
Nocera Inferiore 4
Poplar 4
Qingdao 4
Rio de Janeiro 4
Salvador 4
Secaucus 4
Totale 8.524
Salva come PNG Salva come JPEG
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 103
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 99
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 80
A pharmacological study of dopaminergic receptors in planaria 74
L’alimentazione del paziente parkinsoniano 70
Apomorphine and lisuride infusion. A comparative chronic study 65
Gastrointestinal dysfunction in Parkinson's disease 63
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 62
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 62
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 62
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 61
Modification of respiratory function parameters in patients with severe Parkinson's disease 60
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 60
Side-effects of subcutaneous apomorphine in Parkinson's disease 59
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 58
Adherence to antiparkinson medication in a multicenter European study 58
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 58
One year treatment with lisuride delivery pump in Parkinson's disease 57
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 57
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 57
Neuroprotection in Parkinson's disease: clinical trials 56
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 56
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 56
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 55
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 55
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 54
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 54
Case Study 10 53
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 53
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 53
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 53
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 52
Transient left bundle branch block following intravenous lisuride bolus 52
Managing the critical problems of advanced Parkinson's disease 52
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 52
Use of Apomorphine in Parkinson’s Disease 52
The coefficient of friction in Parkinson's disease gait 52
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 51
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 51
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 51
Transient atrial fibrillation after subcutaneous apomorphine bolus 51
Management of gastrointestinal alterations in Parkinson's disease 50
Jejunal delivery of levodopa methyl ester 50
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 50
Levodopa: A new look at an old friend 50
A pharmacological study of cocaine activity in planaria 50
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 50
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 50
Multicenter trial of L-Deprenyl in Parkinson disease 49
Instrumental diagnosis of multiple system atrophy 49
Antagonist effect of terguride in Parkinson's disease 49
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 49
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 49
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 49
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 49
Parkinson's Disease: Non-motor and non-dopaminergic Features 48
Constipation in Parkinson's Disease 48
Combination of two different dopamine agonists in the management of Parkinson's disease 48
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 48
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 48
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 48
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 48
Emergencies in Parkinson's disease 47
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 47
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 47
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 47
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 47
Motor fluctuations in levodopa treatment: clinical pharmacology 47
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder 47
Continuous dopamine-receptor stimulation in advanced Parkinson's disease 47
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 47
Effects of terguride in patients with Huntington's disease 46
Novel parkin mutations detected in patients with early-onset Parkinson's disease 46
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 46
Alterations of thermoregulation in Parkinson's disease 46
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 46
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease 46
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson’s disease: a systematic review and meta-analysis 45
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 45
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy 45
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 45
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 45
Clinica Neurologica 45
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies 44
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 44
Transient cardiac arrest during continuous intravenous infusion of apomorphine 44
Clinical implications of sustained dopaminergic stimulation. 44
Obstacles to the development of a neuroprotective therapy for Parkinson's disease 44
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients 44
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 44
Determination of apomorphine in human plasma by alumina extraction and high-performance liquid chromatography with electrochemical detection 44
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 44
Dual dopamine agonist treatment in Parkinson's disease 44
Prevention and treatment of motor fluctuations 44
Timed Up and Go test and wearable inertial sensor: a new combining tool to assess change in subject with Parkinson’s disease after automated mechanical peripheral stimulation treatment 44
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 44
Optimising levodopa therapy for the management of Parkinson's disease 44
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications 44
Gastrointestinal, urological, and sleep problems in parkinson's disease 43
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 43
Totale 5.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.403 0 0 36 8 44 170 83 39 63 47 1.746 167
2021/20222.486 11 761 758 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.630 127 591 159 126 95 387 118 185 389 24 90 339
2025/20261.230 499 553 178 0 0 0 0 0 0 0 0 0
Totale 12.124